Literature DB >> 576870

Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.

R P Verhoeven, T J Visser, R Doctor, G Hennemann, M A Schalekamp.   

Abstract

Plasma thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) were measured in 16 patients with Graves' disease. Patients were studied under the following conditions: first without any treatment, then, during beta-adrenergic blockade with propranolol, and finally after euthyroidism had been attained by carbimazole. During propranolol T3/T4 ratio decreased, whereas T4 remained unchanged. After carbimazole T3/T4 ratio returned to its pretreatment value. rT3/T4 ratio showed opposite changes. These results suggest that peripheral conversion of T4 into T3 and rT3 in hyperthyroidism is, at least partly, dependent on the functional status of the beta-adrenergic system. Suppressed peripheral conversion of T4 into T3 during beta-adrenergic blocking agents may contribute to the beneficial effects of these drugs in thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576870     DOI: 10.1210/jcem-44-5-1002

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Beta-adrenergic blocking drugs and thyroid function.

Authors: 
Journal:  Br Med J       Date:  1977-10-22

2.  Sequential deiodination of thyroxine in rat liver homogenate.

Authors:  T J Visser; D Fekkes; R Docter; G Hennemann
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  The spectrum of thyroid disorders in systemic lupus erythematosus.

Authors:  Kundan Kumar; Alakes Kumar Kole; Partha Sarathi Karmakar; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

5.  A study of long acting propranolol in the early management of hyperthyroidism.

Authors:  G R Jones; J H Lazarus; D Wynford-Thomas
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Nadolol in thyrotoxicosis.

Authors:  N R Peden; T E Isles; I H Stevenson; J Crooks
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.

Authors:  P Heyma; R G Larkins; L Higginbotham; K W Ng
Journal:  Br Med J       Date:  1980-07-05

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  Effect of timolol on clinical features and echocardiographic assessment of left ventricular function in hyperthyroidism.

Authors:  B E Griffiths; F M Creagh; J H Lazarus; R John; S Kadury
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

10.  The effects of amiodarone on thyroid function.

Authors:  N S Jaggarao; J Sheldon; E N Grundy; R Vincent; D A Chamberlain
Journal:  Postgrad Med J       Date:  1982-11       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.